Credit Suisse’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,406,441
Closed -$186M 4242
2018
Q4
$186M Sell
1,406,441
-213,626
-13% -$27.4M 0.19% 85
2018
Q3
$216M Buy
1,620,067
+207,713
+15% +$31.1M 0.19% 80
2018
Q2
$225M Buy
1,412,354
+313,173
+28% +$46.4M 0.22% 70
2018
Q1
$157M Sell
1,099,181
-252,132
-19% -$34.5M 0.15% 127
2017
Q4
$180M Buy
1,351,313
+388,313
+40% +$49.6M 0.16% 109
2017
Q3
$120M Buy
963,000
+306,317
+47% +$42.2M 0.12% 172
2017
Q2
$92.3M Buy
656,683
+356,263
+119% +$44.5M 0.09% 206
2017
Q1
$33.9M Buy
300,420
+240,876
+405% +$28.1M 0.03% 577
2016
Q4
$6.26M Buy
59,544
+32,897
+123% +$3.54M 0.01% 1497
2016
Q3
$3.36M Sell
26,647
-520
-2% -$66.1K ﹤0.01% 1965
2016
Q2
$3.75M Sell
27,167
-706
-3% -$93.4K ﹤0.01% 1839
2016
Q1
$3.87M Buy
27,873
+6,721
+32% +$922K ﹤0.01% 1717
2015
Q4
$3.41M Sell
21,152
-829
-4% -$128K ﹤0.01% 1882
2015
Q3
$2.93M Sell
21,981
-5,775
-21% -$753K ﹤0.01% 1981
2015
Q2
$3.18M Sell
27,756
-3,725
-12% -$445K ﹤0.01% 2157
2015
Q1
$3.76M Buy
31,481
+11,022
+54% +$1.47M ﹤0.01% 1893
2014
Q4
$2.98M Buy
20,459
+4,980
+32% +$625K ﹤0.01% 2198
2014
Q3
$2.04M Sell
15,479
-73,604
-83% -$9.69M ﹤0.01% 2475
2014
Q2
$11.1M Buy
89,083
+52,717
+145% +$6.81M 0.01% 1317
2014
Q1
$5.83M Buy
36,366
+2,716
+8% +$447K 0.01% 1638
2013
Q4
$4.53M Buy
33,650
+17,344
+106% +$2.23M ﹤0.01% 1930
2013
Q3
$1.77M Sell
16,306
-20,420
-56% -$2.21M ﹤0.01% 2498
2013
Q2
$3.11M Buy
+36,726
New +$3.29M ﹤0.01% 1943

Credit Suisse's ATHN Position: Q1 2019 in Review

Credit Suisse sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 1,406,441 shares — an estimated $186M sold.

Credit Suisse first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $225M in Q2 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Credit Suisse reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Credit Suisse sold 1,406,441 Athenahealth, Inc. shares in Q1 2019, an estimated $186M.
  • Credit Suisse first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
  • Credit Suisse's Athenahealth, Inc. position peaked at $225M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Credit Suisse's 13F filing for Q1 2019, filed 14 May 2019.